Koers Guided Therapeutics, Inc.
Aandelen
GTHP
US40171F5017
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0873 USD | -12,70% | -12,26% | -43,13% |
Omzet 2022 | 13K 12,16K | Omzet 2023 | 98K 91,66K | Marktkapitalisatie | 8,31 mln. 7,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -4 mln. -3,74 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,81 mln. | EV/omzet 2022 | 1.118 x |
Nettoliquiditeiten 2022 | 50K 46,76K | Nettoschuld 2023 | 1,47 mln. 1,37 mln. | EV/omzet 2023 | 99,7 x |
K/w-verhouding 2022 |
-1,96
x | K/w-verhouding 2023 |
-2,09
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 56,2% |
1 dag | -12,70% | ||
1 week | -12,26% | ||
Lopende maand | -24,42% | ||
1 maand | -28,44% | ||
3 maanden | -39,79% | ||
6 maanden | -45,81% | ||
Lopend jaar | -43,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 27-10-92 |
Founder | 68 | 27-10-92 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 10-04-06 |
Richard Blumberg
BRD | Director/Board Member | 67 | 10-11-16 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 27-10-92 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,0873 | -12,70% | 25 099 |
24-04-24 | 0,1 | -7,41% | 4 050 |
23-04-24 | 0,108 | +18,68% | 5 219 |
22-04-24 | 0,091 | -8,54% | 651 |
18-04-24 | 0,0995 | +9,34% | 475 |
uitgestelde koers OTC Markets, 26 april 2024 om 20:03 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-43,13% | 5,58 mln. | |
+8,07% | 218 mld. | |
+6,59% | 182 mld. | |
+11,26% | 132 mld. | |
+26,57% | 108 mld. | |
+13,35% | 52,98 mld. | |
-0,62% | 47,59 mld. | |
-0,93% | 39,96 mld. | |
+11,54% | 39,22 mld. | |
+26,76% | 26,94 mld. |